Obalon Therapeutics Inc. (NASDAQ: OBLN) stock declines during pre-market. What is happening?
Obalon Therapeutics Inc. (NASDAQ: OBLN) stock gained by 22.03% at the last close whereas the OBLN stock price falls by 2.08% in the pre-market session. Obalon Therapeutics Inc. based in San Diego-based is a company that focuses on making and commercializing novel technologies for weight loss. Recent Update OBLN announced that the special shareholders meeting […]
Obalon Therapeutics Inc. soared in the recent premarket trading session here’s why
In the premarket trading session, at last check, Obalon Therapeutics Inc. (OBLN) stock had surged by 6.48% to $3.12. OBLN stock previously closed session at $2.93. The stock volume traded 7.17 million shares. In the past year up-to-date OBLN shares had jumped by 285.53%. In the past week the shares saw a surge of 19.59%. […]
Obalon Therapeutics, Inc. (OBLN) Stock Skyrockets after Class-Action Lawsuit Controversy Dies Down
Obalon Therapeutics, Inc. (OBLN) stock prices skyrocketed by 30.45% as of the market closing on May 10th, 2021, bringing the price per share up to USD$2.87 at the end of the trading day. OBLN’s Merger with ReShape November 10th, 2020 saw the pioneer of the FDA-approved balloon system for obesity treatment announce that it had […]
Obalon Therapeutics, Inc. (OBLN) Stock Undergoes Volatility as Pandemic Regulations Relaxed
Obalon Therapeutics, Inc. (OBLN) stock prices were down by 15.13% as of the market closing on May 6th, 2021, bringing the price per share down to USD$2.02. Subsequent pre-market fluctuations have seen the stock rally by 9.90%, bringing it up to UD$2.22. Merger with ReShape Lifesciences The pioneer of the FDA-approved balloon system of treatment […]
Does The 49% Jump In Obalon Therapeutics (OBLN) After Hours Make Any Sense?
Yesterday, the medical technology company Obalon Therapeutics, Inc. (NASDAQ: OBLN) has seen its stock price rising 48.87% in extended trading. During the regular session, the stock came uprising 18% to close the trading at $3.54. Investors’ sentiment is likely to rise in anticipation of the company releasing its quarterly results this week. However, there was […]
